| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/02/2010 | US7655458 Endostatin for use in the treatment of cancer and tumor metastasis |
| 02/02/2010 | US7655447 ZSIG33-like polynucleotides |
| 02/02/2010 | US7655444 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents |
| 02/02/2010 | US7655438 Antisense polynucleotide; cancer; polypeptide comprising the protein encoded by the polynucleotide sequence |
| 02/02/2010 | US7655432 Nucleotide sequences coding serine/threonine kinase for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 02/02/2010 | US7655425 Uses of a chemokine receptor able to bind to MCP-1, MIP-1α and/or RANTES |
| 02/02/2010 | US7655420 Identifying sclerostin antagonist via abilty to prevent apoptosis; treating osteoporosis |
| 02/02/2010 | US7655412 Useful to form complexes having an affinity to targets of interest; verotoxin subunit B |
| 02/02/2010 | US7655408 PCA3 messenger RNA species in benign and malignant prostate tissues |
| 02/02/2010 | US7655402 Diagnoses and therapeutics for cancer |
| 02/02/2010 | US7655398 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 02/02/2010 | US7655257 Impermeable reservoir divided into water-swellable agent/drug chambers; fluid from environment imbibed through semipermeable plug into the water-swellable agent chamber releasing drug through a back-diffusion regulating outlet; delivering leuprolide acetate for advanced prostate cancer for 2 years |
| 02/02/2010 | US7655254 A reservoir containing a suspension formulation comprising a non-aqueous, single-phase, viscous vehicle of benzyl benzoate and polyvinylpyrrolidone and a dispersion of particles of interferon, carbohydrate, methionine, and a buffer; staility; hepatitus C; continuous processing; side effect reduction |
| 02/02/2010 | US7655249 vaccine including a polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy |
| 02/02/2010 | US7655246 Chlamydia protein, gene sequence and uses thereof |
| 02/02/2010 | US7655242 Defensin-inducing agents |
| 02/02/2010 | US7655239 Peptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 02/02/2010 | US7655237 obesity, metabolic syndrome, arteriosclerotic disease, arterial hypertension and functional ovaric hyperandrogenism |
| 02/02/2010 | US7655236 Lanthionine antibiotic compositions and methods |
| 02/02/2010 | US7655230 Co-administration of a tissue plasminogen activator, anti-CD11b antibody and anti-CD18 antibody in stroke |
| 02/02/2010 | US7655227 Using a substance capable of inhibiting the binding between parathyroid hormone-related peptide (PTHrP) and a receptor; humanized anti-parathyroid hormone related protein 1-34 (anti-PTHrP (1-34)) antibody |
| 02/02/2010 | US7655226 Treatment of Pompe's disease |
| 02/02/2010 | US7655224 Neural stem cells and use thereof for brain tumor therapy |
| 02/02/2010 | US7655223 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 02/02/2010 | US7655222 increase the production of monocytic cells or moncyte cell progenitors by culturing bone marrow or blood cells with a polypeptide for use in treatment and prevention of viral hepatitis diseases; N-terminal methionine; rheumatoid arthritis, multiple sclerosis, myasthenia gravis, systemic lupus, leukemia |
| 02/02/2010 | US7655221 Methods of treating disease with random copolymers |
| 02/02/2010 | US7655216 nontarget antigen to sensitize a patient's CD8+ T cells followed with administration of a vaccine comprising a target antigen (such as a tumor-associated antigen or a pathogen-associated antigen); cancer and autoimmune diseases |
| 02/02/2010 | US7654999 Tissue volume reduction |
| 02/02/2010 | CA2460306C Stable and taste masked pharmaceutical dosage form using porous apatite grains |
| 02/02/2010 | CA2439051C Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 02/02/2010 | CA2426043C Modulating angiogenesis |
| 02/02/2010 | CA2410305C Preparations comprising combinations of enzyme inhibitors, and the use thereof |
| 02/02/2010 | CA2407994C Reductive alkylation process |
| 02/02/2010 | CA2360228C Treatment of tumor metastases and cancer |
| 02/02/2010 | CA2358581C Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 02/02/2010 | CA2332561C Compound capable of inhibiting the binding of a protein to mast cells, use of the compound for the preparation of a drug, a pharmaceutical composition, a method of diagnosing a disease, and a method of selection |
| 02/02/2010 | CA2302779C Recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
| 02/02/2010 | CA2293724C Apaf-1, the ced-4 human homolog, an activator of caspase-3 |
| 02/02/2010 | CA2282842C A method of recovering highly purified vwf or factor viii/vwf-complex |
| 02/02/2010 | CA2257973C T cell antigen receptor peptides |
| 02/02/2010 | CA2230885C Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 02/02/2010 | CA2180425C Purified primate ctla-8 antigens and related reagents |
| 02/02/2010 | CA2160937C Survival motor neuron (smn) gene: a gene for spinal muscular atrophy |
| 02/02/2010 | CA2160898C Alimentative infusion liquids for administration through peripheral vein |
| 02/01/2010 | CA2638190A1 Treatment of als |
| 01/28/2010 | WO2010011994A2 Polypeptides and uses thereof |
| 01/28/2010 | WO2010011952A2 Highly potent peptides to control cancer and neurodegenerative diseases |
| 01/28/2010 | WO2010011947A2 AMYLOID ß PEPTIDE ANALOGUES, OLIGOMERS THEREOF, PROCESSES FOR PREPARING AND COMPOSITIONS COMPRISING SAID ANALOGUES OR OLIGOMERS, AND THEIR USES |
| 01/28/2010 | WO2010011890A2 Cancer peptide therapeutics |
| 01/28/2010 | WO2010011767A2 Compositions and methods for treating symptoms associated with menopause, hormonal variations and arthritis |
| 01/28/2010 | WO2010011693A2 Proteins containing expanded polyglutamine tracts induce mitochondrial fragmentation by disrupting mitochondrial fusion |
| 01/28/2010 | WO2010011600A2 Method for removal or inactivation of heparin |
| 01/28/2010 | WO2010011597A2 Treatment of obesity and related disorders |
| 01/28/2010 | WO2010011566A1 Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors |
| 01/28/2010 | WO2010011555A1 Csf biomarkers for the prediction of cognitive decline in alzheimer's disease patients |
| 01/28/2010 | WO2010011533A2 Compositions and methods for increasing serum antioxidant concentrations |
| 01/28/2010 | WO2010011347A2 Clip inhibitors and methods of modulating immune function |
| 01/28/2010 | WO2010011343A2 Methods for treating viral disorders |
| 01/28/2010 | WO2010011315A2 Proteins for use in diagnosing and treating infection and disease |
| 01/28/2010 | WO2010011313A2 Ligation of stapled polypeptides |
| 01/28/2010 | WO2010011310A1 Methods for diagnosis and prognosis of skin cancer |
| 01/28/2010 | WO2010011119A1 Ophthalmic solution for corneal enlargement |
| 01/28/2010 | WO2010010594A1 Method for the expression in plant of the glutamic acid decarboxylase (gad65) and related expression vectors the present invention concerns a method of expression in plant of glutamic acid decarboxylase (gad65), particularly a mutated form of human gad65 (gad65mut), and expression vectors thereof. |
| 01/28/2010 | WO2010010555A2 Transdermal system for extended delivery of incretins and incretin mimetic peptides |
| 01/28/2010 | WO2010010299A2 Dermocosmetic composition, aesthetic treatment method using the composition, and use of the composition for lightening the pigmentation of the skin |
| 01/28/2010 | WO2010010179A1 The tuberculosis rv2386c protein, compositions and uses thereof |
| 01/28/2010 | WO2010010051A1 Tnfsf single chain molecules |
| 01/28/2010 | WO2010010000A2 Screening method, diagnostic method and small nucleic acid for the treatment of cns disorders |
| 01/28/2010 | WO2010009985A2 Therapeutic combination comprising an aurora kinase inhibitor and antiproliferative agents |
| 01/28/2010 | WO2010009872A1 Modified cck peptides |
| 01/28/2010 | WO2010009808A1 Preparation and iontophorectic device for the transdermal application of active ingredients |
| 01/28/2010 | WO2010009762A1 Interferon and an agent inducing inhibition of protein phosphatase 2a such as interleukin- 1 and optionally ribavirin for the treatment of hbv or hcv infection |
| 01/28/2010 | WO2010009732A1 Therapeutic use of a growth factor, metrnl |
| 01/28/2010 | WO2010009557A1 Tissue kallikrein for the treatment of parkinson's disease |
| 01/28/2010 | WO2010009534A1 Methods for the treatment, prevention and diagnosis of lipid metabolism associated diseases |
| 01/28/2010 | WO2010009524A1 Use of the angiotensin-(1-7) peptide, analogues, agonists and derivatives thereof for the treatment of painful conditions |
| 01/28/2010 | WO2009152462A3 Method of regulating cell growth using a proteasome inhibitor |
| 01/28/2010 | WO2009147384A3 Peptides derived from the neural-restrictive silencer factor rest and use thereof |
| 01/28/2010 | WO2009128076A3 Methods of generating and using procollagen |
| 01/28/2010 | WO2009120995A3 Collagen-binding synthetic peptidoglycans, preparation, and methods of use |
| 01/28/2010 | WO2009114539A9 Neuroprotective integrin-binding peptide and angiopoietin-1 treatments |
| 01/28/2010 | WO2009102966A3 Bmp-7 for use in treating vascular sclerosis |
| 01/28/2010 | WO2009063459A3 Synthetic peptide copolymers for treatment of neurodevelopmental disorders |
| 01/28/2010 | WO2009051845A3 Biodegradable implants with controlled bulk density |
| 01/28/2010 | WO2009024631A3 A combination of inhibitors of tgfbeta-1 and matrix metalloproteins for use in the treatment of bone metastases, bone resorption and hypercalcaemia |
| 01/28/2010 | WO2009012493A3 H-antigen binding polypeptides and methods of use |
| 01/28/2010 | WO2007024941A3 Polyvalent vaccine |
| 01/28/2010 | WO2007000768A9 Gliomedin, fragments thereof and methods of using same |
| 01/28/2010 | WO2006020326A9 Methods of identifying compounds that modulate protein activity |
| 01/28/2010 | WO2004101763A9 Novel lipolytic enzyme lip1 |
| 01/28/2010 | WO2004005463A9 Tumor antigens bfa4 and bcy1 for prevention and/or treatment of cancer |
| 01/28/2010 | WO2003016502A9 Tramdorins and methods of using tramdorins |
| 01/28/2010 | US20100024075 Method for Controlling Plant-Parasitic Nematode Infections in Plants |
| 01/28/2010 | US20100023101 Biocompatible composites |
| 01/28/2010 | US20100022756 Trimerising Module |
| 01/28/2010 | US20100022459 Peptides directed for diagnosis and treatment of amyloid-associated diseases |
| 01/28/2010 | US20100022458 Methods for treating acute acoustic trauma |
| 01/28/2010 | US20100022457 Sustained release glp-1 receptor modulators |
| 01/28/2010 | US20100022456 Dimeric Prolactin Receptor Ligands |
| 01/28/2010 | US20100022455 Therapeutic agents comprising elastin-like peptides |